Indivior PLC Indivior to Participate in Upcoming Investor Event (0290U)
20 Noviembre 2023 - 8:55AM
UK Regulatory
TIDMINDV
RNS Number : 0290U
Indivior PLC
20 November 2023
Indivior To Participate in Jefferies Investor Event on November
21(st)
Slough, UK, and Richmond, VA, November 20, 2023 - Indivior PLC
(LSE/NASDAQ: INDV) today announced that it will participate in the
following investor event:
-- Jefferies Investor Event (Indivior CEO Fireside Chat) - Virtual
Mark Crossley, Chief Executive Officer, will participate in a
fireside chat at 9:00 a.m. US Eastern Time on November 21(st) . The
fireside chat will be publicly available and can be accessed using
the following weblink:
Webcast link
About Indivior
Indivior is a global pharmaceutical company working to help
change patients' lives by developing medicines to treat substance
use disorders (SUD) and serious mental illnesses. Our vision is
that all patients around the world will have access to
evidence-based treatment for the chronic conditions and
co-occurring disorders of SUD. Indivior is dedicated to
transforming SUD from a global human crisis to a recognized and
treated chronic disease. Building on its global portfolio of OUD
treatments, Indivior has a pipeline of product candidates designed
to both expand on its heritage in this category and potentially
address other chronic conditions and co-occurring disorders of SUD,
including alcohol use disorder and cannabis use disorder.
Headquartered in the United States in Richmond, VA, Indivior
employs more than 1,000 individuals globally and its portfolio of
products is available in 37 countries worldwide. Visit
www.indivior.com to learn more. Connect with Indivior on LinkedIn
by visiting www.linkedin.com/company/indivior .
Contact:
Jason Thompson
Vice President, Investor Relations
Tel: 804-402-7123 or jason.thompson@indivior.com
Tim Owens
Director, Investor Relations
Tel: 804-263-3978 or timothy.owens@indivior.com
###
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCNKKBPQBDDBDB
(END) Dow Jones Newswires
November 20, 2023 09:55 ET (14:55 GMT)
Indivior (LSE:INDV)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Indivior (LSE:INDV)
Gráfica de Acción Histórica
De May 2023 a May 2024